Published in Curr Osteoporos Rep on September 01, 2012
Low-bone-mass phenotype of deficient mice for the cluster of differentiation 36 (CD36). PLoS One (2013) 0.82
Disentangling the body weight-bone mineral density association among breast cancer survivors: an examination of the independent roles of lean mass and fat mass. BMC Cancer (2013) 0.77
Visceral fat measured by DXA is associated with increased risk of non-spine fractures in nonobese elderly women: a population-based prospective cohort analysis from the São Paulo Ageing & Health (SPAH) Study. Osteoporos Int (2016) 0.75
Association between obesity and femoral neck strength according to age, sex, and fat distribution. Osteoporos Int (2017) 0.75
Bone Cell Bioenergetics and Skeletal Energy Homeostasis. Physiol Rev (2017) 0.75
Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19
Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA (2012) 33.54
Obesity in children and young people: a crisis in public health. Obes Rev (2004) 18.76
Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun (1999) 14.25
Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr (2000) 11.69
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int (2006) 11.05
Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell (2000) 7.87
Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest (2002) 5.83
Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med (2004) 4.87
Circulating ghrelin levels are decreased in human obesity. Diabetes (2001) 4.28
Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell (1993) 4.19
Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell (2010) 4.16
Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol (2007) 4.11
Bone "mass" and the "mechanostat": a proposal. Anat Rec (1987) 4.05
The epidemiology of nonfatal injuries among US children and youth. Am J Public Health (1995) 3.93
Review of the prevalence and incidence of eating disorders. Int J Eat Disord (2003) 3.56
Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med (2007) 3.36
Mechanisms of anabolic therapies for osteoporosis. N Engl J Med (2007) 3.33
The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab (2004) 3.13
Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med (2000) 2.80
Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone (2004) 2.75
Epidemiology of children's fractures. J Pediatr Orthop B (1997) 2.62
XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev (1998) 2.58
Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes (2009) 2.43
Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program. Cell Mol Life Sci (2009) 2.35
Increased bone marrow fat in anorexia nervosa. J Clin Endocrinol Metab (2009) 2.31
Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J Clin Pathol (2002) 2.28
Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest (1996) 2.20
Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. J Clin Endocrinol Metab (2009) 2.20
Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone (2003) 2.17
Osteoporosis is associated with increased marrow fat content and decreased marrow fat unsaturation: a proton MR spectroscopy study. J Magn Reson Imaging (2005) 2.07
Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab (2005) 2.03
Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res (2006) 2.01
Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol Metab (2011) 1.99
Static vs dynamic loads as an influence on bone remodelling. J Biomech (1984) 1.96
Adjustment of fat-free mass and fat mass for height in children aged 8 y. Int J Obes Relat Metab Disord (2002) 1.96
Obesity is not protective against fracture in postmenopausal women: GLOW. Am J Med (2011) 1.95
Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol (2002) 1.93
The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass. JAMA (1991) 1.93
Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women. Obesity (Silver Spring) (2010) 1.93
Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metab (2006) 1.91
Annual incidence of unintentional injury among 54,000 children. Inj Prev (1996) 1.91
Evidence for the necessity to systematically assess micronutrient status prior to bariatric surgery. Obes Surg (2008) 1.87
Adiponectin and its receptors are expressed in bone-forming cells. Bone (2004) 1.86
Visceral fat is a negative predictor of bone density measures in obese adolescent girls. J Clin Endocrinol Metab (2010) 1.80
Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun (2005) 1.80
Effects of anorexia nervosa on clinical, hematologic, biochemical, and bone density parameters in community-dwelling adolescent girls. Pediatrics (2004) 1.73
Does obesity really make the femur stronger? BMD, geometry, and fracture incidence in the women's health initiative-observational study. J Bone Miner Res (2009) 1.71
Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice. J Bone Miner Res (2005) 1.70
Pref-1 regulates mesenchymal cell commitment and differentiation through Sox9. Cell Metab (2009) 1.70
Medical findings in outpatients with anorexia nervosa. Arch Intern Med (2005) 1.69
Decreased bone density in adolescent girls with anorexia nervosa. Pediatrics (1990) 1.67
Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res (2005) 1.64
Leptin inhibits osteoclast generation. J Bone Miner Res (2002) 1.64
The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab (1995) 1.64
Serum adiponectin and bone mineral density in women. J Clin Endocrinol Metab (2007) 1.63
Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J Clin Endocrinol Metab (1989) 1.61
Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab (2002) 1.58
The association between fracture and obesity is site-dependent: a population-based study in postmenopausal women. J Bone Miner Res (2012) 1.58
Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab (1996) 1.54
MRI-measured bone marrow adipose tissue is inversely related to DXA-measured bone mineral in Caucasian women. Osteoporos Int (2006) 1.52
Fat and bone. Arch Biochem Biophys (2010) 1.52
How many children remain fracture-free during growth? a longitudinal study of children and adolescents participating in the Dunedin Multidisciplinary Health and Development Study. Osteoporos Int (2002) 1.51
Serum 1,25-dihydroxy vitamin D is inversely associated with body mass index. Eur J Nutr (2008) 1.51
Assessment of macronutrient and micronutrient intake in women with anorexia nervosa. Int J Eat Disord (2000) 1.49
Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab (2003) 1.49
Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling. J Cell Biochem (2002) 1.49
Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab (2002) 1.48
Patients with high bone mass phenotype exhibit enhanced osteoblast differentiation and inhibition of adipogenesis of human mesenchymal stem cells. J Bone Miner Res (2007) 1.48
Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Horm Res (2003) 1.47
Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J Cell Biochem (2006) 1.46
Altered neuroregulation of GH secretion in viscerally obese premenopausal women. J Clin Endocrinol Metab (2001) 1.45
Reciprocal relation between marrow adiposity and the amount of bone in the axial and appendicular skeleton of young adults. J Clin Endocrinol Metab (2008) 1.44
Ghrelin directly regulates bone formation. J Bone Miner Res (2004) 1.44
Long-term fracture risk among women with anorexia nervosa: a population-based cohort study. Mayo Clin Proc (1999) 1.43
Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab (2005) 1.43
The role of the epidermal growth factor-like protein dlk in cell differentiation. Histol Histopathol (2000) 1.42
Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis. J Clin Endocrinol Metab (2011) 1.40
Serum parathyroid hormone level is associated with body mass index. The 5th Tromsø study. Eur J Endocrinol (2004) 1.40
Determinants of bone mineral density in obese premenopausal women. Bone (2010) 1.36
Secretory dynamics of leptin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab (2005) 1.33
Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women. J Clin Endocrinol Metab (2008) 1.32
Bone formation is impaired in a model of type 1 diabetes. Diabetes (2005) 1.32
Contribution of trochanteric soft tissues to fall force estimates, the factor of risk, and prediction of hip fracture risk. J Bone Miner Res (2007) 1.29
Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab (1991) 1.29
Promotion of bony ingrowth by frequency-specific, low-amplitude mechanical strain. Clin Orthop Relat Res (1994) 1.29
Anorexia nervosa. Immaturity of the 24-hour luteinizing hormone secretory pattern. N Engl J Med (1974) 1.28
Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system--II. Immunohistochemical analysis. Neuroscience (1986) 1.28
Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders--a nationwide register study. Int J Eat Disord (2002) 1.27
Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab (2004) 1.26
Leptin is an effective treatment for hypothalamic amenorrhea. Proc Natl Acad Sci U S A (2011) 1.26
Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab (1996) 1.26
Nutrient intake in community-dwelling adolescent girls with anorexia nervosa and in healthy adolescents. Am J Clin Nutr (2006) 1.25
Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept (1994) 1.25
Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab (1995) 1.23
The relationship between obesity and injuries among U.S. adults. Am J Health Promot (2007) 1.23
Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa. J Clin Endocrinol Metab (2009) 1.22
Effect of cortisone treatment on the active transport of calcium by the small intestine. J Clin Invest (1971) 1.21
Insulin-like effects of visfatin on human osteoblasts. Calcif Tissue Int (2007) 1.20
Preadipocyte factor-1 is associated with marrow adiposity and bone mineral density in women with anorexia nervosa. J Clin Endocrinol Metab (2009) 1.18
Activation of p53 by MEG3 non-coding RNA. J Biol Chem (2007) 3.07
A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab (2003) 2.68
MEG3 noncoding RNA: a tumor suppressor. J Mol Endocrinol (2012) 2.41
Increased bone marrow fat in anorexia nervosa. J Clin Endocrinol Metab (2009) 2.31
Uncoupling of cardiovascular risk markers in adolescent girls with anorexia nervosa. J Pediatr (2006) 2.06
Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab (2005) 2.03
Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women. Obesity (Silver Spring) (2010) 1.93
Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab (2004) 1.81
Visceral fat is a negative predictor of bone density measures in obese adolescent girls. J Clin Endocrinol Metab (2010) 1.80
Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions. Endocrinology (2009) 1.78
Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res (2010) 1.76
Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab (2011) 1.74
Effects of anorexia nervosa on clinical, hematologic, biochemical, and bone density parameters in community-dwelling adolescent girls. Pediatrics (2004) 1.73
Medical findings in outpatients with anorexia nervosa. Arch Intern Med (2005) 1.69
Fear conditioning and extinction: influence of sex and menstrual cycle in healthy humans. Behav Neurosci (2006) 1.68
Fracture risk and areal bone mineral density in adolescent females with anorexia nervosa. Int J Eat Disord (2014) 1.64
Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis. Am J Med (2009) 1.63
Marrow fat and bone--new perspectives. J Clin Endocrinol Metab (2013) 1.60
Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab (2002) 1.58
FGF21 and the late adaptive response to starvation in humans. J Clin Invest (2015) 1.55
Estradiol modulates medial prefrontal cortex and amygdala activity during fear extinction in women and female rats. Biol Psychiatry (2011) 1.51
Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab (2003) 1.49
Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab (2002) 1.48
Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metab (2003) 1.44
Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab (2005) 1.43
Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls. Am J Physiol Endocrinol Metab (2008) 1.41
Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors. J Clin Endocrinol Metab (2005) 1.34
Secretory dynamics of leptin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab (2005) 1.33
Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas. J Clin Endocrinol Metab (2008) 1.33
Loss of expression of GADD45 gamma, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis. J Clin Endocrinol Metab (2002) 1.29
Activation of paternally expressed genes and perinatal death caused by deletion of the Gtl2 gene. Development (2010) 1.28
Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metab (2006) 1.27
Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab (2004) 1.26
Changing patterns in diagnosis and therapy of acromegaly over two decades. J Clin Endocrinol Metab (2008) 1.25
Nutrient intake in community-dwelling adolescent girls with anorexia nervosa and in healthy adolescents. Am J Clin Nutr (2006) 1.25
A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegaly. J Clin Endocrinol Metab (2005) 1.23
Comparison of DXA and CT in the assessment of body composition in premenopausal women with obesity and anorexia nervosa. Obesity (Silver Spring) (2010) 1.23
Distal radius in adolescent girls with anorexia nervosa: trabecular structure analysis with high-resolution flat-panel volume CT. Radiology (2008) 1.23
Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa. J Clin Endocrinol Metab (2009) 1.22
Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa-1. J Clin Endocrinol Metab (2007) 1.20
Increased expression of angiogenic genes in the brains of mouse meg3-null embryos. Endocrinology (2010) 1.19
Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma. J Clin Endocrinol Metab (2014) 1.19
Young women with cold-activated brown adipose tissue have higher bone mineral density and lower Pref-1 than women without brown adipose tissue: a study in women with anorexia nervosa, women recovered from anorexia nervosa, and normal-weight women. J Clin Endocrinol Metab (2012) 1.18
Preadipocyte factor-1 is associated with marrow adiposity and bone mineral density in women with anorexia nervosa. J Clin Endocrinol Metab (2009) 1.18
Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa. J Clin Endocrinol Metab (2007) 1.18
Effects of exercise training and metformin on body composition and cardiovascular indices in HIV-infected patients. AIDS (2004) 1.18
Decreased nocturnal oxytocin levels in anorexia nervosa are associated with low bone mineral density and fat mass. J Clin Psychiatry (2011) 1.17
Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. J Bone Miner Res (2011) 1.16
Hormone predictors of abnormal bone microarchitecture in women with anorexia nervosa. Bone (2009) 1.15
Leptin levels are associated with decreased depressive symptoms in women across the weight spectrum, independent of body fat. Clin Endocrinol (Oxf) (2012) 1.14
Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa. Bone (2008) 1.13
The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas. J Clin Endocrinol Metab (2006) 1.12
Bone metabolism in adolescent athletes with amenorrhea, athletes with eumenorrhea, and control subjects. Pediatrics (2008) 1.11
Marrow fat and preadipocyte factor-1 levels decrease with recovery in women with anorexia nervosa. J Bone Miner Res (2012) 1.11
Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study. J Clin Endocrinol Metab (2008) 1.11
Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism. J Clin Psychiatry (2004) 1.11
Anorexia nervosa and osteoporosis. Rev Endocr Metab Disord (2006) 1.10
Diagnostic errors after inferior petrosal sinus sampling. J Clin Endocrinol Metab (2004) 1.09
Regional body composition in adolescents with anorexia nervosa and changes with weight recovery. Am J Clin Nutr (2003) 1.09
Endocrine abnormalities in anorexia nervosa. Nat Clin Pract Endocrinol Metab (2008) 1.07
Food motivation circuitry hypoactivation related to hedonic and nonhedonic aspects of hunger and satiety in women with active anorexia nervosa and weight-restored women with anorexia nervosa. J Psychiatry Neurosci (2012) 1.06
Role of cortisol in menstrual recovery in adolescent girls with anorexia nervosa. Pediatr Res (2006) 1.04
Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab (2004) 1.03
Waist to hip ratio and trunk to extremity fat (DXA) are better surrogates for IMCL and for visceral fat respectively than for subcutaneous fat in adolescent girls. Nutr Metab (Lond) (2010) 1.02
Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa. J Clin Endocrinol Metab (2009) 1.01
Oxytocin secretion is associated with severity of disordered eating psychopathology and insular cortex hypoactivation in anorexia nervosa. J Clin Endocrinol Metab (2012) 1.01
Stress response circuitry hypoactivation related to hormonal dysfunction in women with major depression. J Affect Disord (2010) 1.01
Differential effects of metformin and exercise on muscle adiposity and metabolic indices in human immunodeficiency virus-infected patients. J Clin Endocrinol Metab (2004) 1.01
Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomas. Am J Pathol (2011) 1.01
Cortical microstructure and estimated bone strength in young amenorrheic athletes, eumenorrheic athletes and non-athletes. Bone (2012) 1.00
Regional cerebral brain metabolism correlates of neuroticism and extraversion. Depress Anxiety (2006) 1.00
Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents. J Clin Endocrinol Metab (2005) 1.00
Effects of recombinant human growth hormone in anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab (2010) 1.00
Growth hormone and ghrelin responses to an oral glucose load in adolescent girls with anorexia nervosa and controls. J Clin Endocrinol Metab (2004) 1.00
Effects of recombinant human growth hormone therapy in adults with Prader-Willi syndrome: a meta-analysis. Clin Endocrinol (Oxf) (2012) 0.99
Women with anorexia nervosa: finite element and trabecular structure analysis by using flat-panel volume CT. Radiology (2010) 0.98
Appetite-regulating hormones cortisol and peptide YY are associated with disordered eating psychopathology, independent of body mass index. Eur J Endocrinol (2010) 0.97
Hormonal and body composition predictors of soluble leptin receptor, leptin, and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity. J Clin Endocrinol Metab (2004) 0.96
Cyclic AMP stimulates MEG3 gene expression in cells through a cAMP-response element (CRE) in the MEG3 proximal promoter region. Int J Biochem Cell Biol (2006) 0.96
Clinical Review#: Potential cardiac valve effects of dopamine agonists in hyperprolactinemia. J Clin Endocrinol Metab (2010) 0.96
Growth hormone deficiency is associated with decreased quality of life in patients with prior acromegaly. J Clin Endocrinol Metab (2009) 0.95
Effects of rhIGF-1 administration on surrogate markers of bone turnover in adolescents with anorexia nervosa. Bone (2009) 0.95
Delayed remission after transsphenoidal surgery in patients with Cushing's disease. J Clin Endocrinol Metab (2010) 0.95
Bone metabolism in adolescent boys with anorexia nervosa. J Clin Endocrinol Metab (2008) 0.95
Serum prolactin levels among outpatients with major depressive disorder during the acute phase of treatment with fluoxetine. J Clin Psychiatry (2006) 0.94
Neuroendocrine consequences of anorexia nervosa in adolescents. Endocr Dev (2009) 0.93
Adolescent girls with anorexia nervosa have impaired cortical and trabecular microarchitecture and lower estimated bone strength at the distal radius. J Clin Endocrinol Metab (2013) 0.93
Hormonal determinants of regional body composition in adolescent girls with anorexia nervosa and controls. J Clin Endocrinol Metab (2005) 0.91
Bone health in anorexia nervosa. Curr Opin Endocrinol Diabetes Obes (2011) 0.91
Increased carbohydrate induced ghrelin secretion in obese vs. normal-weight adolescent girls. Obesity (Silver Spring) (2009) 0.91
Prognostic indicators of changes in bone density measures in adolescent girls with anorexia nervosa-II. J Clin Endocrinol Metab (2007) 0.91
Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas. J Clin Endocrinol Metab (2007) 0.91
Gonadotropinomas. Semin Reprod Med (2002) 0.91
Effects of risedronate on bone density in anorexia nervosa. J Clin Endocrinol Metab (2004) 0.90
Psychotropic medication use in anorexia nervosa between 1997 and 2009. Int J Eat Disord (2012) 0.90
Proton stereotactic radiosurgery in management of persistent acromegaly. Endocr Pract (2008) 0.90
Effects of estrogen and recombinant human insulin-like growth factor-I on ghrelin secretion in severe undernutrition. J Clin Endocrinol Metab (2004) 0.90
Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement. J Clin Endocrinol Metab (2010) 0.90
Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm. J Clin Endocrinol Metab (2003) 0.89
Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant. J Clin Endocrinol Metab (2002) 0.89